|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 34.19 USD | -1.30% |
|
+2.77% | -26.16% |
| 05-15 | Collegium Pharmaceutical, Inc. Announces Appointment of Michael Donovan as Director | CI |
| 05-12 | Collegium completes acquisition of Azstarys® from Corium Therapeutics | RE |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Neutral | Bearish | Neutral |
| Resistance | 39.33 | 39.33 | 49.84 |
| Spread/Res. | -13.07% | -13.07% | -31.40% |
| Spread/Supp. | +12.17% | +12.17% | +13.70% |
| Support | 30.48 | 30.48 | 30.07 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- COLL Stock
- Charts Collegium Pharmaceutical, Inc.
Select your edition
All financial news and data tailored to specific country editions
